Cited by 822Genomic variations and chromosomal abnormalitiesCancer Genomics and DiagnosticsChromatin Remodeling and Cancer

The DOI matches its Crossref record; 164 of the 167 references it cites were found in a registry or an index.

Chromosome aberrations in solid tumors

Albertson, Donna G, Collins, Colin, McCormick, Frank, Gray, Joe W·2003·Nature Genetics

DOI 10.1038/ng1215

Open this paper in CoChat — free account

Abstract

Chromosome aberrations in human solid tumors are hallmarks of gene deregulation and genome instability. This review summarizes current knowledge regarding aberrations, discusses their functional importance, suggests mechanisms by which aberrations may form during cancer progression and provides examples of clinical advances that have come from studies of chromosome aberrations.

Integrity signals

Registry

Crossref · 10.1038/ng1215

Cites

164 of 164 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

The hallmarks of cancer
Hanahan, D., & Weinberg, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)81683-9 · Cited by 29,219
Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications
Sørlie, T., Perou, C. M., Tibshirani, R. J., Aas, T., Geisler, S. B., Johnsen, H., Hastie, T. J., Eisen, M. B., van de Rijn, M., Jeffrey, S. S., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.191367098 · Cited by 11,506
Mutations of the BRAF gene in human cancer
Davies, H., Bignell, G. R., Cox, C., Stephens, P., Edkins, S., Clegg, S., Teague, J., Woffendin, H., Garnett, M. J., Bottomley, W., et al. (2002) · Nature · doi:10.1038/nature00766 · Cited by 10,674
Gene expression profiling predicts clinical outcome of breast cancer
van 't Veer, L. J., Dai, H., van de Vijver, M. J., He, Y. D., Hart, A. A. M., Mao, M., Peterse, H. L., van der Kooy, K., Marton, M. J., Witteveen, A. T., et al. (2002) · Nature · doi:10.1038/415530a · Cited by 9,536
Studies of the HER-2/ neu Proto-Oncogene in Human Breast and Ovarian Cancer
Slamon, D. J., Godolphin, W. J., Jones, L. A., Holt, J. A., Wong, S., Keith, D. E., Levin, W. J., Stuart, S. G., Udove, J. A., Ullrich, A., et al. (1989) · Science · doi:10.1126/science.2470152 · Cited by 6,817
A Gene-Expression Signature as a Predictor of Survival in Breast Cancer
van de Vijver, M. J., He, Y. D., Veer, L. V. ‘., Dai, H. A., Hart, A. A. M., Voskuil, D. W., Schreiber, G. J., Peterse, J. L., Roberts, C., Marton, M. J., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa021967 · Cited by 6,474
Real time quantitative PCR.Preprint
Heid, C., Stevens, J., Livak, K. J., & Williams, P. (1996) · Genome Research · doi:10.1101/gr.6.10.986 · Cited by 6,180
The fundamental role of epigenetic events in cancer
Jones, P. A., & Baylin, S. B. (2002) · Nature Reviews Genetics · doi:10.1038/nrg816 · Cited by 5,648
PTEN , a Putative Protein Tyrosine Phosphatase Gene Mutated in Human Brain, Breast, and Prostate Cancer
Li, J., Yen, C., Liaw, D., Podsypanina, K., Bose, S., Wang, S. I., Puc, J., Miliaresis, C., Rodgers, L., McCombie, R., et al. (1997) · Science · doi:10.1126/science.275.5308.1943 · Cited by 4,785
Comparative Genomic Hybridization for Molecular Cytogenetic Analysis of Solid Tumors
Kallioniemi, A. H., Kallioniemi, O., Sudar, D., Rutovitz, D., Gray, J. W., Waldman, F., & Pinkel, D. (1992) · Science · doi:10.1126/science.1359641 · Cited by 3,293
Self-citation

Show all 167 references

Sorted by citations

Items 501–600 of 822

Genomic characterization of a newly established esophageal squamous cell carcinoma cell line from China and published esophageal squamous cell carcinoma cell lines
Li, X., Tian, D., Guo, Y. Z., Qiu, S., Xu, Z., Deng, W., & Su, M. (2020) · Cancer Cell International · doi:10.1186/s12935-020-01268-x · Cited by 7
The contributions of extrachromosomal DNA elements in neoplasm progression.
Hong, J., Zheng, S., & Jiang, D. (2021) · PubMed Central · Cited by 8
ESR1 amplification in breast cancer: controversy resolved?
Albertson, D. G. (2012) · The Journal of Pathology · doi:10.1002/path.3999 · Cited by 8
Self-citation
Cyclin-dependent kinase-specific activity predicts the prognosis of stage I and stage II non-small cell lung cancer
Kubo, H., Suzuki, T., Matsushima, T., Ishihara, H., Uchino, K., Suzuki, S., Tada, S., Yoshimura, M., & Kondo, T. (2014) · BMC Cancer · doi:10.1186/1471-2407-14-755 · Cited by 8
Detección de aneuploidías del cromosoma 17 y deleción del gen TP53 en una amplia variedad de tumores sólidos mediante hibridación in situ fluorescente bicolor
Herrera, J. C., Isaza, L. F., Ramírez, J. L., Vásquez, G., & Peña, C. M. M. (2010) · Biomédica · doi:10.7705/biomedica.v30i3.273 · Cited by 8
Bone marrow micrometastases in different solid tumors: Pathogenesis and importance
Athanassiadou, P. P., & Grapsa, D. (2008) · Surgical Oncology · doi:10.1016/j.suronc.2008.04.004 · Cited by 8
Functional antagonism of TMPRSS2-ERG splice variants in prostate cancer
Rastogi, A., Tan, S., Mohamed, A. A., Chen, Y., Hu, Y., Petrovics, G., Sreenath, T., Kagan, J., Srivastava, S., McLeod, D. G., et al. (2014) · Genes & Cancer · doi:10.18632/genesandcancer.25 · Cited by 8
Insights for hepatitis C virus related hepatocellular carcinoma genetic biomarkers: Early diagnosis and therapeutic intervention
Ezzat, W. M., & Amr, K. S. (2016) · World Journal of Hepatology · doi:10.4254/wjh.v8.i30.1251 · Cited by 8
Radiation-Induced Changes of microRNA Expression Profiles in Radiosensitive and Radioresistant Leukemia Cell Lines with Different Levels of Chromosome Abnormalities
Liamina, D., Sibirnyj, W., Khokhlova, A. V., Saenko, V. V., Rastorgueva, E. V., Fomin, A. N., & Saenko, Y. (2017) · Cancers · doi:10.3390/cancers9100136 · Cited by 8
Molecular Mechanisms of Chromium-Induced Carcinogenesis
Browning, C. L., Speer, R. M., & Wise, J. P. (2017) · Molecular and integrative toxicology · doi:10.1007/978-3-319-55448-8_7 · Cited by 8
Integrated analysis of expression and genome alteration reveals putative amplified target genes in esophageal cancer
Sugimoto, T., Arai, M., Shimada, H., Hata, A., & Seki, N. (2007) · Oncology Reports · doi:10.3892/or.18.2.465 · Cited by 8
Copy Number Variations
Lü, J., & Liu, Z. (2010) · Wiley eBooks · doi:10.1002/9780470958964.ch2 · Cited by 8
Development, anti-proliferative activity, multi-target kinase inhibition against CHK1, PIM1, and CDK-2, and computational insights of new thiazole-based hybrids
Altwaijry, N., Othman, I. M. M., Anwar, M. M., Nosier, S. S., Saleh, A., Tashkandi, N. Y., & Nossier, E. S. (2026) · RSC Advances · doi:10.1039/d6ra00253f · Cited by 7
‘Chromosomal Rainbows’ Detect Oncogenic Rearrangements of Signaling Molecules in Thyroid Tumors
O’Brien, B., Jossart, G. H., Ito, Y., Greulich‐Bode, K. M., Weier, J. F., Munné, S., Clark, O. H., & Weier, H. G. (2010) · PubMed Central · doi:10.2172/1011038 · Cited by 7
Two novel unbalanced whole arm translocations are frequently detected in cervical squamous cell carcinoma
Backsch, C., Pauly, B., Liesenfeld, M., Scheungraber, C., Gajda, M. R., Mrasek, K., Liehr, T., Clad, A., Schröck, E., Runnebaum, I. B., et al. (2011) · Cancer Genetics · doi:10.1016/j.cancergen.2011.10.009 · Cited by 7
Application of Proteomics in Cancer Study
Azodi, M. Z., Rezaei–Tavirani, M., Mortazavian, A. M., Vafaee, R., Zali, H., & Kashani, M. S. (2013) · Cited by 7
Spatial quantitation of FISH signals in diploid versus aneuploid nuclei
Shete, A., Rao, P. H., Pati, D., & Merchant, F. A. (2013) · Cytometry Part A · doi:10.1002/cyto.a.22426 · Cited by 7
Functional analysis—Make or break for cancer predictability
Deniz, M., Holzmann, K., & Wiesmüller, L. (2013) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/j.mrfmmm.2013.03.009 · Cited by 7
Metabolic restriction of cancer cells in vitro causes karyotype contraction—an indicator of cancer promotion?
Li, Y., Héroux, P., & Kyrychenko, I. (2011) · Tumor Biology · doi:10.1007/s13277-011-0262-6 · Cited by 9
Low Level of TERC Gene Amplification between Chronic Myeloid Leukaemia Patients Resistant and Respond to Imatinib Mesylate Treatment
Ashari, Z. S. M., Sulong, S., Hassan, R., Husin, A., Sim, G. A., & Fadilah, S. A. W. (2014) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2014.15.4.1863 · Cited by 7
CNAReporter: a GenePattern pipeline for the generation of clinical reports of genomic alterations
Kotliarov, Y., Bozdag, S., Cheng, H., Wuchty, S., Zenklusen, J.-C., & Fine, H. A. (2010) · BMC Medical Genomics · doi:10.1186/1755-8794-3-11 · Cited by 7
Insights into the cell fate decision-making processes from chromosome structural reorganizations
Chu, X., & Wang, J. (2022) · Biophysics Reviews · doi:10.1063/5.0107663 · Cited by 9
Wound Healing Is a First Response in a Cancerous Pathway: Hyperplasia Developments to 4n Cell Cycling in Dysplasia Linked to Rb-Inactivation
Walen, K. H. (2015) · Journal of Cancer Therapy · doi:10.4236/jct.2015.610099 · Cited by 8
Micro (Nano)plastics Vitiation of Genetic Material: Systematic Review of Genotoxic Biomarkers and Model Bioindicators
Alimba, C. G., Adesida, S. O., Owonikoko, M. W., & Oteyola, A. O. (2025) · Journal of Applied Toxicology · doi:10.1002/jat.4928 · Cited by 6
The Importance of Monitoring Non-clonal Chromosome Aberrations (NCCAs) in Cancer Research
Heng, E., Thanedar, S., & Heng, H. H. (2024) · Methods in molecular biology · doi:10.1007/978-1-0716-3946-7_4 · Cited by 6
Single-Cell Molecular Characterization to Partition the Human Glioblastoma Tumor Microenvironment Genetic Background
Lessi, F., Franceschi, S., Morelli, M., Menicagli, M., Pasqualetti, F., Santonocito, O. S., Gambacciani, C., Pieri, F., Aquila, F., Aretini, P., et al. (2022) · Cells · doi:10.3390/cells11071127 · Cited by 7
Fluorescence in situ hybridization detection of chromosome 7 and/or 17 polysomy as a prognostic marker for cholangiocarcinoma
Deenonpoe, R., Sa-Ngiamwibool, P., Watcharadetwittaya, S., Thanee, M., Intuyod, K., Kongpan, T., Padthaisong, S., Nutalai, R., Chamgramol, Y., & Pairojkul, C. (2022) · Scientific Reports · doi:10.1038/s41598-022-11945-8 · Cited by 6
Chromosomal aneuploidies and combinational fluorescence in situ hybridization probe panels are useful for predicting prognosis for esophageal squamous cell carcinoma
Hao, J., Yao, H., Dai, G.-Y., Kang, W., Jia, X., Xu, X., Cai, Y., Zhan, Q., Wang, G., & Wang, M. (2014) · Journal of Gastroenterology · doi:10.1007/s00535-014-0961-z · Cited by 6
Breaking point: the genesis and impact of structural variation in tumours
Ewing, A., & Semple, C. A. M. (2018) · F1000Research · doi:10.12688/f1000research.16079.1 · Cited by 6
Molecular Techniques
Bubendorf, L., Grote, H. J., & Syrjänen, K. J. (2008) · Elsevier eBooks · doi:10.1016/b978-141604208-2.10036-3 · Cited by 6
A Study on Gene Selection and Classification Algorithms for Classification of Microarray Gene Expression Data
Yeo, L. C., & Deris, S. (2012) · Jurnal Teknologi · doi:10.11113/jt.v43.780 · Cited by 6
Reference-free prediction of rearrangement breakpoint reads
Wijaya, E., Shimizu, K., Asai, K., & Hamada, M. (2014) · Bioinformatics · doi:10.1093/bioinformatics/btu360 · Cited by 5
Genetic diagnosis of patients with esophageal cancer using FISH
Awut, I., Niyaz, M., HUIZHONG, X., Biekemitoufu, H., Yan, Z. H., Zhang, Z., Sheyhedin, I., CHANGMIN, Z., WEI, Z., & HAO, W. (2010) · Oncology Letters · doi:10.3892/ol_00000142 · Cited by 5
XomAnnotate: Analysis of Heterogeneous and Complex Exome- A Step towards Translational Medicine
Talukder, A. K., Ravishankar, S., Sasmal, K., Gandham, S. K., Prabhukumar, J., Achutharao, P., Barh, D., & Blasi, F. (2015) · PLoS ONE · doi:10.1371/journal.pone.0123569 · Cited by 5
Detection of copy number variants and loss of heterozygosity from impure tumor samples using whole exome sequencing data
Liu, X., Li, A., Xi, J., Feng, H., & Wang, M. (2018) · Oncology Letters · doi:10.3892/ol.2018.9150 · Cited by 5
Translational Research in Oncology
Qazi, A. S., Akbar, S., Saeed, R. F., & Bhatti, M. Z. (2020) · Springer eBooks · doi:10.1007/978-981-15-1067-0_11 · Cited by 5
P53/MDM2 Complex-Based Targeted Strategies in Colon Adenocarcinoma
Niotis, A., Tsiambas, E., Dimitroulis, D., Sarlanis, H., Falidas, E., Kavantzas, N., & Constantinides, C. A. (2023) · Acta Medica Academica · doi:10.5644/ama2006-124.398 · Cited by 5
Genetic Alterations of SMYD4 in Solid Tumors Using Integrative Multi-Platform Analysis
Santana, B. L. O., de Loyola, M. B., Gualberto, A. C. M., & Pittella-Silva, F. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25116097 · Cited by 5
The Role of Tumor Microenvironment in Oral Cancer
Fukuda, M., Ohmori, Y., & Sakashit, H. (2012) · InTech eBooks · doi:10.5772/33020 · Cited by 5
The Etiology of Cancer
Vail, D. M., Thamm, D. H., & Liptak, J. M. (2019) · Elsevier eBooks · doi:10.1016/b978-0-323-59496-7.00001-3 · Cited by 6
Genome-based versus gene-based theory of cancer: Possibleimplications for clinical practice
Todorović‐Raković, N. (2011) · Journal of Biosciences · doi:10.1007/s12038-011-9099-9 · Cited by 5
[Application of multicolor fluorescence in situ hybridization to early diagnosis of esophageal squamous cell carcinoma].
Yao, H., He, S., Wu, Y., Wang, X., Han, Y., Xu, X., Cai, Y., Wang, G., & Wang, M. (2008) · PubMed · Cited by 5
Advancement in characterization of genomic alterations for improved diagnosis, treatment and prognostics in cancer
Zhou, X. C., Yu, T., Cole, S. W., & Wong, D. T. (2005) · Expert Review of Molecular Diagnostics · doi:10.1586/14737159.6.1.39 · Cited by 5
Deep learning-based tumor segmentation and radiogenomic model for predicting EGFR amplification and assessing intratumoural heterogeneity in glioblastoma
Liu, J., Shen, C., Jiang, S., Wu, Y., Tu, J., Bao, Y., Li, H., Wang, N. Y., Liu, Y., Xiong, J., et al. (2025) · Journal Of Big Data · doi:10.1186/s40537-025-01221-7 · Cited by 4
Cytogenomic aberrations associated with prostate cancer
Gu, G., & Brothman, A. R. (2011) · Cancer Genetics · doi:10.1016/j.cancergencyto.2010.10.003 · Cited by 4
A crowdsourcing database for the copy-number variation of the Spanish population
López-López, D., Roldán, G., Fernández-Rueda, J. L., Bostelmann, G., Carmona, R., Aquino, V., Pérez-Florido, J., Ortuño, F. M., Pita, G., Núñez‐Torres, R., et al. (2023) · Human Genomics · doi:10.1186/s40246-023-00466-8 · Cited by 6
Evaluation of HER2Neu Status in Periampullary Cancers in Tertiary Care Centre in Northern India: A Three-Year Retrospective Study
Qayoom, S., Agarwal, A., Agarwal, P., Anand, A., Raj, R., Gupta, S., & Singh, A. K. (2023) · Cureus · doi:10.7759/cureus.46646 · Cited by 4
Determination of matrix metalloproteinase 9 (MMP-9) protein expression in laryngeal squamous cell carcinomas based on digital image analysis.
Papadas, T. A., Ss, N., Ns, M., Stathas, T., Karabekos, N. C., & Tsiambas, E. (2013) · PubMed · Cited by 4
Soft Tissue Sarcomas
El-Naggar, A. M., Leprivier, G., & Sorensen, P. H. B. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-396967-5.00022-0 · Cited by 4
Microsatellite Instability in Colorectal Cancer
Parine, N. R., Varsha, R. S., & Alanazi, M. S. (2016) · InTech eBooks · doi:10.5772/65429 · Cited by 4
Impact of Chromosome 9 Numerical Imbalances in Oral Squamous Cell Carcinoma: A Pilot Grid-Based Centromere Analysis
Kyrodimos, E., Chrysovergis, A., MASTRONIKOLIS, N. S., Tsiambas, E., Riziotis, C., Roukas, D., Fotiades, P. P., Stavraka, C., Ragos, V., Paschopoulos, M. E., et al. (2020) · Diagnostics · doi:10.3390/diagnostics10070501 · Cited by 4
Tyrosine Kinase Inhibitors, Antibody-Drug Conjugates, and Proteolysis-Targeting Chimeras: The Pharmacology of Cutting-Edge Lung Cancer Therapies
Carlisle, J. W., & Harvey, R. D. (2021) · American Society of Clinical Oncology Educational Book · doi:10.1200/edbk_320667 · Cited by 4
KAT5 histone acetyltransferase mutations in cancer cells
Hardison, K. L., Hawk, T. M., Bouley, R. A., & Petreaca, R. C. (2022) · PubMed Central · doi:10.17912/micropub.biology.000676 · Cited by 4
MET-FISH Evaluation Algorithm: Proposal of a Simplified Method
Castiglione, R., Alidousty, C., & Holz, B. (2022) · Journal of Cancer Science and Clinical Therapeutics · doi:10.26502/jcsct.5079180 · Cited by 4
Selective inference for false discovery proportion in a hidden Markov model
Perrot-Dockès, M., Blanchard, G., Neuvial, P., & Roquain, É. (2023) · Test · doi:10.1007/s11749-023-00886-7 · Cited by 4
Génétique du cancer colorectal
Ferron, M., Praz, F., & Pocard, M. D. (2005) · Annales de Chirurgie · doi:10.1016/j.anchir.2005.02.014 · Cited by 6
TAFFYS: An Integrated Tool for Comprehensive Analysis of Genomic Aberrations in Tumor Samples
Liu, Y., Li, A., Feng, H., & Wang, M. (2015) · PLoS ONE · doi:10.1371/journal.pone.0129835 · Cited by 4
Molecular pathological diagnosis for early esophageal cancer in Kazakh patients
Awut, I., Niyaz, M., Biekemitoufu, H., Zhang, Z., Sheyhedin, I., & HAO, W. (2011) · Oncology Letters · doi:10.3892/ol.2011.547 · Cited by 4
Gestion des variations du nombre de séquences génomiques (CNV) en génétique humaine constitutionnelle utilisant l’hybridation génomique comparative en microréseau d’ADN (HGCM)
Némos, C., Bursztejn, A. ‐., & Jonveaux, P. (2008) · Pathologie Biologie · doi:10.1016/j.patbio.2008.03.015 · Cited by 6
Comparative genomic hybridization (CGH) analysis of chromosomal aberrations in Iranian patients with invasive ductal carcinoma breast cancer.
Ghaffari, S. R., Sabokbar, T., Pour, P. N., Dastan, J., Mehrkhani, F., Shoraka, S., Mohagheghi, M. A., Tirgari, F., & Mosavi-Jarrahi, A. (2008) · PubMed · Cited by 4
Comparative Genomic Hybridization on BAC Arrays
Coe, B. P., Lockwood, W. W., Chari, R., & Lam, W. L. (2009) · Methods in molecular biology · doi:10.1007/978-1-60327-192-9_2 · Cited by 4
Toxicological Aspects in the Regulation of Gene Therapy Medicinal Products
Rousseau, C. F., Sabbah-Petrover, E., Revaud, D., Voisin, E., Ruthsatz, M., & Chiavaroli, C. (2021) · Springer eBooks · doi:10.1007/978-3-030-57499-4_141 · Cited by 4
Probing the chromosome 9p21 region susceptible to DNA double-strand breaks in human cells in vivo by restriction enzyme transfer
Sato, M., Sasaki, H., Kazui, T., Yokota, J., & Kohno, T. (2005) · Oncogene · doi:10.1038/sj.onc.1208750 · Cited by 4
Genomic approaches in cancer biology
Matros, E., Wang, Z. C., Richardson, A. L., & Iglehart, J. D. (2004) · Surgery · doi:10.1016/j.surg.2004.05.040 · Cited by 4
ESR1 fusion proteins in breast cancer: distinguishing oncogenic drivers from passenger events
Gherghelas, A.-M., & Toseland, C. P. (2026) · Oncogene · doi:10.1038/s41388-026-03813-w · Cited by 3
A Robust Framework of Chromosome Straightening With Vit-Patch Gan
Song, S., Wang, J., Cheng, F., Cao, Q., Zuo, Y., Lei, Y., Yang, R., Yang, C., Coenen, F., Meng, J., et al. (2023) · IEEE International Symposium on Biomedical Imaging (ISBI) · doi:10.1109/isbi53787.2023.10230388 · Cited by 3
Impact of Amplified Oncogenes on Salivary Gland Carcinomas
PAPANIKOLAOU, V. S., Chrysovergis, A., ASIMAKOPOULOS, A. D., Spyropoulou, D., Ragos, V., PAPANASTASIOU, G., Papouliakos, S. M., Mastronikoli, S., Roukas, D., Tsiambas, E., et al. (2023) · Cancer Diagnosis & Prognosis · doi:10.21873/cdp.10250 · Cited by 3
Understanding oral cancer at molecular level: The new frontier
Manchanda, K., Sarkar, A. D., Chauhan, I., Sharma, N., Fotedar, S., & Fotedar, V. (2015) · Annals of Tropical Medicine and Public Health · doi:10.4103/1755-6783.162314 · Cited by 3
Proteomics-Based Disease Biomarkers
Misek, D. E., Kondo, T., & Duncan, M. W. (2011) · International Journal of Proteomics · doi:10.1155/2011/894618 · Cited by 3
Acquired Chromosomal Abnormalities and Their Potential Formation Mechanisms in Solid Tumours
Aygün, N. (2017) · InTech eBooks · doi:10.5772/67733 · Cited by 4
Recurrent Pregnancy Loss Associated Cytogenetic and Genetic Anomalies – Study from Eastern India
Bhattacharjee, K., Pal, S., Banerjee, E., & Mukherjee, S. (2024) · International Journal of experimental research and review · doi:10.52756/ijerr.2024.v37spl.007 · Cited by 3
Neoplasia
Damjanov, I. (2009) · Elsevier eBooks · doi:10.1016/b978-0-323-05594-9.00005-2 · Cited by 3
Mutational Signatures in Salivary Gland Carcinomas
Chrysovergis, A., PAPANIKOLAOU, V. S., Spyropoulou, D., Roukas, D., ASIMAKOPOULOS, A. D., PAPANASTASIOU, G., Mastronikoli, S., Falidas, E., Papouliakos, S. M., Tsiambas, E., et al. (2023) · Cancer Diagnosis & Prognosis · doi:10.21873/cdp.10233 · Cited by 3
A model for random genetic damage directing selection of diploid or aneuploid tumours
Bazeley, P. S., Nestor‐Kalinoski, A. L., Ways, J. A., Liu, S., Ramdath, R. S., Matsui, S., & Allison, D. C. (2011) · Cell Proliferation · doi:10.1111/j.1365-2184.2011.00746.x · Cited by 3
Fluorescence In Situ Hybridization for the Detection of Chromosome Aberrations and Aneuploidy Induced by Environmental Toxicants
Pacchierotti, F., & Sgura, A. (2008) · Methods in molecular biology · doi:10.1007/978-1-59745-548-0_13 · Cited by 3
▪ Catastrophes and Complex Networks in Genomically Unstable Tumorigenesis
Solé, R. V. (2010) · CRC Press eBooks · doi:10.1201/b10407-9 · Cited by 3
Оцінка впливу професійного опромінення на цитогенетичні показники лімфоцитів периферичної крові
Domina, E. A. (2018) · Reports of the National Academy of Sciences of Ukraine · doi:10.15407/dopovidi2018.10.112 · Cited by 3
FAM35A / SHLD2 / RINN2 : A novel determinant of double strand break repair pathway choice and genome stability in cancer
Fackrell, K., Bobins, L., Parul, & Tomida, J. (2020) · Environmental and Molecular Mutagenesis · doi:10.1002/em.22379 · Cited by 3
Identification of Copy Number Alterations from Next-Generation Sequencing Data
Nabavi, S., & Zare, F. (2022) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-91836-1_4 · Cited by 5
Corrections for mRNA extraction and sample normalization errors find increased mRNA levels may compensate for cancer haplo‐insufficiency
Weaver, D. A., Nestor‐Kalinoski, A. L., Craig, K., Gorris, M. A., Parikh, T., Mabry, H., & Allison, D. C. (2013) · Genes Chromosomes and Cancer · doi:10.1002/gcc.22133 · Cited by 3
Acquired chromosome abnormalities: the cytogenetics of cancer
Gollin, S. M. (2005) · Encyclopedia of Genetics, Genomics, Proteomics and Bioinformatics · doi:10.1002/047001153x.g102204 · Cited by 3
Mechanisms Underlying Neoplasia-Associated Genomic Rearrangements
Fioretos, T. (2007) · Humana Press eBooks · doi:10.1007/978-1-59745-039-3_23 · Cited by 3
SNP-CGH technologies for genomic profiling of LOH and copy number
Peiffer, D. A., & Gunderson, K. L. (2006) · Cited by 3
Analysis of Aneuploidy Spectrum From Whole-Genome Sequencing Provides Rapid Assessment of Clonal Variation Within Established Cancer Cell Lines
Khalil, A. I. S., Chattopadhyay, A., & Sanyal, A. (2021) · Cancer Informatics · doi:10.1177/11769351211049236 · Cited by 2
Targeted Liposome Garcinol Formulation for the Treatment of Colon Cancer: Pharmacological and Toxicological Evaluation
Javvaji, K., Vangala, V., Deshpande, S., Matta, S., Kandimalla, R. J. L., Puvvada, N., Mudiam, M. K. R., & Misra, S. (2025) · ACS Applied Bio Materials · doi:10.1021/acsabm.5c00860 · Cited by 2
Multi-Omics and Functional Analysis of BFSP1 as a Prognostic and Therapeutic Target in Liver Hepatocellular Carcinoma
Lee, K.-S., & Kim, J. (2025) · Medicina · doi:10.3390/medicina61122196 · Cited by 2
Bayesian feature selection in high‐dimensional regression in presence of correlated noise
Feldman, G., Bhadra, A., & Kirshner, S. (2014) · Stat · doi:10.1002/sta4.60 · Cited by 2
Typing, grading, and staging of cases of tumor
Bignold, L. P. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-816920-9.00010-9 · Cited by 2
From Banding to BAM Files
Dubuc, A. M. (2020) · Surgical pathology clinics · doi:10.1016/j.path.2020.02.007 · Cited by 2
Scanning window analysis of non-coding regions within normal-tumor whole-genome sequence samples
Torcivia-Rodriguez, J., & Mazumder, R. (2020) · Briefings in Bioinformatics · doi:10.1093/bib/bbaa203 · Cited by 2
Model of Chromosomal Instability in Oral Carcinogenesis and Progression
Giaretti, W. (2012) · InTech eBooks · doi:10.5772/31883 · Cited by 2
Characterization of Chromosomal Translocations in Mouse Models of Hematological Malignancies Using Spectral Karyotyping, FISH, and Immunocytochemistry
Ried, T., & Difilippantonio, M. J. (2011) · Springer eBooks · doi:10.1007/978-0-387-69805-2_9 · Cited by 2
Increasing the discovery power of -omics studies
Clevert, D.-A., Mayr, A., Mitterecker, A., Klambauer, G., Valsesia, A., Forner, K., Tuefferd, M., Talloen, W., Wojcik, J., Göhlmann, H. W. H., et al. (2013) · Systems Biomedicine · doi:10.4161/sysb.25774 · Cited by 2
Sorting Cancer Karyotypes by Elementary Operations
Ozery-Flato, M., & Ron Shamir, A. (2008) · Lecture notes in computer science · doi:10.1007/978-3-540-87989-3_16 · Cited by 2
Genetics of uveal melanoma
Mensink, H. W., Paridaens, D. A., & de Klein, A. (2009) · Expert Review of Ophthalmology · doi:10.1586/eop.09.53 · Cited by 2
Genome organization, instabilities, stem cells, and cancer
Pazhanisamy, S. K., & Jyothi, V. (2009) · Journal of Stem Cells and Regenerative Medicine · doi:10.46582/jsrm.0501004 · Cited by 2
Basis for Molecular Genetics in Cancer
Pierron, G. (2015) · Springer eBooks · doi:10.1007/978-3-319-22189-2_3 · Cited by 2
Yeast as Models of Mitotic Fidelity
Torres, E. M. (2015) · Recent results in cancer research/Recent Results in Cancer Research · doi:10.1007/978-3-319-20291-4_7 · Cited by 2
Genomic compartmentalization of gene families encoding core components of metazoan signaling systems
Wong, H., Soh, J., Gordon, P. M. K., Yu, T., Sensen, C. W., Parr, E. J., & Johnston, R. N. (2013) · Genome · doi:10.1139/gen-2013-0021 · Cited by 2
Diallyl disulfide protects against rectal cancer in vivo model of male rabbits: II-Analysis of histological and cytogenetic variations
Tito, N. H., Mohammed, O., Soheir, A. A. E. R., & Yassmin, R. B. (2016) · Journal of Cancer Research and Experimental Oncology · doi:10.5897/jcreo2016.0127 · Cited by 2

Authors: Albertson, D. G., Collins, C., McCormick, F., & Gray, J. W.
Affiliations: University of California, San Francisco (US)
Lawrence Berkeley National Laboratory (US)
Corresponding author: Albertson, Donna G
Gray, Joe W
ORCID: Albertson, Donna G
Collins, Colin
McCormick, Frank
Gray, Joe W
Venue: Nature Genetics
Publisher: Springer Science and Business Media LLC
Published: 2003-07-30
Volume: 34
Issue: 4
Pages: 369-376
ISSN: 1061-4036 (ISSN-L)
1546-1718
DOI: 10.1038/ng1215
OpenAlex: W2060084956
Cited by: 812
References: 167
Citations by year: 2026: 8 · 2025: 11 · 2024: 15 · 2023: 22 · 2022: 26 · 2021: 26 · 2020: 29 · 2019: 27 · 2018: 19 · 2017: 18 · 2016: 19 · 2015: 32 · 2014: 41 · 2013: 68 · 2012: 54
FWCI: 4.93
Type: journal article
Language: en
Open access: closed
Licence: www.springer.com/tdm (tdm)
Locations: Nature Genetics (publishedVersion)
PubMed (publishedVersion)
Funders: Avon Foundation for Women
U.S. Public Health Service
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genomic variations and chromosomal abnormalities
Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Genomics and Diagnostics
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Chromatin Remodeling and Cancer
Keywords: chromosomal abnormalities, solid tumors, genomic instability, gene expression dysregulation, tumor progression, chromosomal instability
MeSH terms: Chromosome Aberrations, Biological Evolution, Humans, Models, Genetic, Neoplasms, Oncogenes, Prognosis, Signal Transduction, Gene Dosage, Receptor Protein-Tyrosine Kinases

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Chromosome aberrations in solid tumors

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks